Previous 10 | Next 10 |
2023-11-11 13:15:07 ET Regeneron Pharmaceuticals, Inc. (REGN) Truist Securities BioPharma Symposium November 08, 2023 03:20 PM ET Company Participants Dr. Len Schleifer - President and Chief Executive Officer Ryan Crowe - Investor Relations Conference Call Part...
2023-11-11 12:49:07 ET Regeneron Pharmaceuticals Inc. (REGN) UBS Biopharma Conference Call November 9, 2023 11:00 AM ET Company Participants Ryan Crowe - Vice President, Investor Relations Brook Jennings - Vice President, Immunology Marketing Conference Call Pa...
2023-11-09 15:15:08 ET More on Intellia Therapeutics Intellia Therapeutics, Inc. (NTLA) Q3 2023 Earnings Call Transcript Intellia Therapeutics, Inc. 2023 Q3 - Results - Earnings Call Presentation Intellia Therapeutics: Massive OpEx Begin To Weigh On HAE Prospects ...
2023-11-09 13:17:55 ET More on Eli Lilly Eli Lilly: Zepbound For Weight Loss FDA Approved - Time To Believe The Hype? Eli Lilly and Co (LLY) Q3 2023 Earnings Conference Call Transcript Eli Lilly and Company 2023 Q3 - Results - Earnings Call Presentation Eli L...
2023-11-09 09:53:00 ET Biotech giant Regeneron (NASDAQ: REGN) and streaming specialist Roku (NASDAQ: ROKU) have been solid performers for most of the year, but both stocks recently jumped following their third-quarter earnings releases. While a single quarterly update rarely...
2023-11-07 07:30:58 ET More on Sanofi Sanofi Spins Off, Investors Spin Out (Rating Downgrade) Sanofi (SNY) Q3 2023 Earnings Call Transcript Sanofi Q3 2023 Earnings Preview: Expect Positive Results, But No Share Price Spike Sanofi shares hit 52-week low amid d...
2023-11-03 13:56:37 ET Summary Regeneron reported strong Q3 2023 results, driven by the growth of Dupixent and Libtayo, as by Eylea holding up against Vabysmo. Claims by Roche of market share gains have not translated into significant erosion for Eylea, as Regeneron managed to fin...
2023-11-03 12:59:13 ET More on BioCryst, Clearside Biomedical, etc. BioCryst Pharmaceuticals, Inc. (BCRX) Q3 2023 Earnings Call Transcript BioCryst Pharmaceuticals: Q3 Earnings May Not Halt This Stock's Bear Run Clearside Biomedical, Inc. (CLSD) Q2 2023 Earnings Call...
2023-11-03 08:40:40 ET More on Regeneron Regeneron Pharmaceuticals, Inc. (REGN) Q3 2023 Earnings Call Transcript Regeneron Pharmaceuticals, Inc. 2023 Q3 - Results - Earnings Call Presentation Regeneron Pharmaceuticals: Game-Changing Discoveries In Healthcare ...
Ten abstracts, including three oral presentations, spotlight the expanding body of evidence supporting odronextamab in follicular lymphoma and diffuse large B-cell lymphoma Additional presentations include the first review of primary endpoint results with longer follow-up from the pivot...
News, Short Squeeze, Breakout and More Instantly...
Regeneron Pharmaceuticals Inc. Company Name:
REGN Stock Symbol:
NASDAQ Market:
Regeneron Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...
2024-07-12 11:00:05 ET Trung Huynh from UBS issued a price target of $1,250.00 for REGN on 2024-07-12 10:18:00. The adjusted price target was set to $1,250.00. At the time of the announcement, REGN was trading at $1092.3075. The overall price target consensus is at $902....
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 3.6% to $0.2493 on volume of 118,503,418 shares Qualigen Therapeutics Inc. (QLGN) rose 94.8% to $0.4 on volume of 100,863,101 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 20.0% to $0.098...